Occudo Quantitative Strategies LP Alector, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$5.86 - $7.93 $160,130 - $216,695	27,326 New	27,326 $164,000
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $133,591 - $248,673	17,463 New	17,463 $177,000
Q1 2021 May 14, 2021	SELL	$14.84 - $22.23 $406,141 - $608,390	-27,368 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.4 - $16.7 $257,259 - $457,045	27,368 New	27,368 $414,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.